GlobeNewswire Inc | Nov 25, 2020 07:00AM EST

November 25, 2020

SOUTH SAN FRANCISCO, Calif., Nov. 25, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc.(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced that the Company will participate in the upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference.

Conference Dates: Tuesday, December 1 to Thursday, December 3, 2020. A link to the fireside chat presentation is available on the Investors section of the Companys website at investors.caredxinc.com.

AboutCareDxCareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACT:

Investor RelationsGreg Chodaczek347-610-7010investor@caredx.com